Page last updated: 2024-08-03 00:49:35

16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione

Description

Cross-References

ID SourceID
PubMed CID14058554
SCHEMBL ID17078378
MeSH IDM0073656

Synonyms (3)

Synonym
16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
SCHEMBL17078378
DTXSID20875414

Research

Studies (112)

TimeframeStudies, This Drug (%)All Drugs %
pre-199053 (47.32)18.7374
1990's45 (40.18)18.2507
2000's12 (10.71)29.6817
2010's2 (1.79)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.86%)6.00%
Case Studies1 (0.86%)4.05%
Observational0 (0.00%)0.25%
Other114 (98.28%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
2003200321.0low000100
nitratesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
1993199828.5low002000
nitritesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
human metabolite1998199826.0low001000
clenbuterolamino alcohol;
dichlorobenzene;
ethanolamines;
primary arylamine;
secondary amino compound;
substituted aniline
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent
1993199331.0low001000
estriol16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid
estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
1980198044.0low010000
norethindrone acetate3-oxo-Delta(4) steroid;
acetate ester;
terminal acetylenic compound
progestin;
synthetic oral contraceptive
1993199928.0low002000
ethinyl estradiol17-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound
xenoestrogen1980199836.2low031000
desoxycorticosterone20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1986198638.0low010000
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1992199232.0low002000
norethindrone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol
progestin;
synthetic oral contraceptive
1985199931.6low025000
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
1985201627.3low015010
triamcinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
1989199432.5low011000
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
2001200123.0low000100
nandrolone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid
human metabolite1986199531.6low016000
medroxyprogesterone17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
contraceptive drug;
progestin;
synthetic oral contraceptive
1984198539.5low020000
dihydrotestosterone17beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
1984200629.4low032200
levonorgestrel17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound
contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
1988199929.8low013000
megestrol17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
1990199432.0low002000
danazol17beta-hydroxy steroid;
terminal acetylenic compound
anti-estrogen;
estrogen antagonist;
geroprotector
1994199430.0low001000
iodinehalide anion;
monoatomic iodine
human metabolite1993199331.0low001000
pregnanolone3-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid
human metabolite;
intravenous anaesthetic;
sedative
1997199727.0low001000
promegestone20-oxo steroid;
3-oxo-Delta(4) steroid
antineoplastic agent;
progesterone receptor agonist;
progestin
1979199536.8low093000
desogestrel17beta-hydroxy steroid;
terminal acetylenic compound
contraceptive drug;
progestin;
synthetic oral contraceptive
1988199531.3low012000
mifepristone3-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound
abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
1987201629.3low0112010
thiazolyl blueorganic bromide saltcolorimetric reagent;
dye
2001200123.0low000100
drospirenone3-oxo-Delta(4) steroid;
steroid lactone
aldosterone antagonist;
contraceptive drug;
progestin
1999199925.0low001000
nomegestrol acetatecorticosteroid hormone1990199432.0low002000
5-alpha-dihydroprogesterone20-oxo steroid;
3-oxo-5alpha-steroid;
C21-steroid hormone
human metabolite;
progestogen
1997199727.0low001000
fulvestrant17beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide
antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
2007200717.0low000100
ici 16438417beta-hydroxy steroid;
3-hydroxy steroid;
tertiary carboxamide
anti-estrogen;
antineoplastic agent;
estrogen receptor antagonist
1993199829.5low004000
zk 1129931997199727.0low001000
ru-283621988198836.0low010000
methyl 4-mercaptobutyrimidateorganonitrogen compound;
oxoacid derivative
1987198737.0low010000
ru 269881985198539.0low010000
4-hydroxyclomiphene1989198935.0medium010000
21-fluoro-16-ethyl-19-norprogesterone1988198836.0medium010000
org 306591995199529.0high002000
org 317101995199529.0low001000
17 alpha-hydroxyprogesterone caproatecorticosteroid hormone1986198638.0low010000
epimestrolsteroid1980198044.0low010000
mibolerone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid
anabolic agent;
androgen
1986199432.6low014000
metribolone17beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid
androgen1982200533.2low063100
tibolone17beta-hydroxy steroid;
terminal acetylenic compound
bone density conservation agent;
hormone agonist
1998200820.0low001200
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1990200029.0low002000
diethylstilbestrololefinic compound;
polyphenol
antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
1984198738.5low020000
afimoxifenephenols;
tertiary amino compound
antineoplastic agent;
estrogen receptor antagonist;
metabolite
1988199632.0low011000
dactinomycinactinomycinmutagen1989198935.0low010000
5 alpha-dihydronorethindrone1985198539.0medium010000
enclomiphene1989198935.0low010000
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
1979199634.6low032000
gestodenesteroidestrogen1988199531.3low012000
alpha-chymotrypsin1990199034.0low001000
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1993199331.0low001000
onapristone1993199828.0low003000
etonogestrel17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound
contraceptive drug;
female contraceptive drug;
progestin
1988199531.3low012000
ru 5866817beta-hydroxy steroid;
3-hydroxy steroid;
aromatic ether;
organofluorine compound;
sulfone
anti-estrogen;
antineoplastic agent;
estrogen receptor antagonist
1996199628.0low001000
3-hydroxytibolone2008200816.0low000100
moxestrol3-hydroxy steroid1986198737.5low020000
acid phosphatase1992199232.0low001000
epidermal growth factor1985199135.7low021000
cyclin d11993200127.0low001100
norgestrel1988201226.7low011010
transforming growth factor alpha1991199133.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Adenocarcinoma01995199529.0low001000
Adenocarcinoma, Basal Cell01995199529.0low001000
Adenoma, Prostatic01981198640.5low020000
Body Weight01993199331.0low001000
Breast Cancer01980201231.4high01525310
Breast Neoplasms01980201231.4high01525310
Cancer of Kidney01984198440.0low010000
Cancer of Ovary01983198838.5low020000
Cancer of Pituitary01986198638.0low010000
Cancer of Prostate01992199232.0low001000
Cancer of the Thyroid01999199925.0low001000
Cancer of the Uterus01983198839.0low030000
Carcinoma01995199529.0low001000
Carcinoma, Anaplastic01995199529.0low001000
Carcinoma, Medullary01999199925.0low001000
Cholelithiasis01991199133.0low001000
Gallstone Disease01991199133.0low001000
Hormone-Dependent Neoplasms01985200031.5low011000
Kidney Neoplasms01984198440.0low010000
Metastase01983198341.0low010000
Neoplasm Metastasis01983198341.0low010000
Osteogenic Sarcoma01992199232.0low001000
Osteosarcoma01992199232.0low001000
Ovarian Neoplasms01983198838.5low020000
Pituitary Neoplasms01986198638.0low010000
Pregnancy01982199736.8low041000
Prostatic Hyperplasia01981198640.5low020000
Prostatic Neoplasms01992199232.0low001000
Sarcoma01984198440.0low010000
Sarcoma, Epithelioid01984198440.0low010000
Thyroid Neoplasms01999199925.0low001000
Uterine Neoplasms01983198839.0low030000
Weight Gain01993199331.0low001000

Long-term Use (1)

ArticleYear
Effects of long-term administration of clenbuterol in mature female rats.
American journal of veterinary research, , Volume: 54, Issue:3
1993

Pharmacokinetics (1)

ArticleYear
[Pharmacokinetics of RU 486 and its active metabolites in humans].
Acta pharmaceutica Hungarica, , Volume: 64, Issue:1
1994

Bioavailability (1)

ArticleYear
Haemoglobin expression in human endometrium.
Human reproduction (Oxford, England), , Volume: 23, Issue:3
2008

Dosage (1)

ArticleYear
Progesterone and dexamethasone inhibition of uterine epithelial cell proliferation: studies with antiprogesterone compounds in the neonatal mouse.
The Journal of steroid biochemistry and molecular biology, , Volume: 46, Issue:2
1993